Lexaria Bioscience Corp. (LEXX) has a market capitalization of $20.85M and trades at $1.02. The 52-week range is 0.46-1.69.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.5, Earnings Per Share (EPS) of $-0.66, annual revenue of $705.92K.
The stock has a beta of 0.48, operates in the Healthcare sector.
